Information for Shareholders and Investors

Latest news and press releases

  • 08 mar, 2016

    Grifols will invest USD 360M to expand its manufacturing capacities for plasma-derived therapies Download (240.1 Kb)

  • 29 feb, 2016

    Grifols’ revenues grow by 17.3% to Euros 3,935 million, and net profit grows by 13.2% reaching Euros 532 million Download (347.1 Kb)

  • 26 jan, 2016

    Grifols invests in the project led by AlbaJuna Therapeutics, a spin-off from IrsiCaixa, to fund the development of therapeutic antibodies against HIV Download (249.7 Kb)